Alert: New Earnings Report (2/28/24)-Amphastar Pharmaceuticals Inc (NASDAQ: AMPH).
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) has reported E.P.S. of $0.75 for its fourth fiscal quarter (ending December 31) versus $0.70 for the same period a year ago — an increase of 7%. Relative to the […]